(NASDAQ: CBLL) Ceribell's forecast annual revenue growth rate of 34.89% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 56.5%.
Ceribell's revenue in 2026 is $82,813,000.On average, 10 Wall Street analysts forecast CBLL's revenue for 2026 to be $4,261,552,867, with the lowest CBLL revenue forecast at $3,980,738,494, and the highest CBLL revenue forecast at $4,444,434,619. On average, 9 Wall Street analysts forecast CBLL's revenue for 2027 to be $5,467,533,749, with the lowest CBLL revenue forecast at $5,134,043,496, and the highest CBLL revenue forecast at $5,762,444,485.
In 2028, CBLL is forecast to generate $7,109,018,032 in revenue, with the lowest revenue forecast at $6,681,675,683 and the highest revenue forecast at $7,477,378,233.